Antibodies detected in samples from 21,730 pregnant women
By:
Paid access
|Oct 2020References
- Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 10th ed. Oxford: Blackwell Scientific Publications, 1997.
- Tijanic N, Jovanovic-Srzentic S, Djokic M. Importance of laboratory analysis in antenatal testing. Bilt Hematol Transfuz 1996;1:11-3.
- Slavkovic B, Vavic N, Pajevic M, Paunovic D, Djokic M. Incidence of red cell antibodies during pregnancy. Bilt Hematol Transfuz 1994;2:49-51.
- Cepulic-Golubic et al. RhD immunoprophylaxis in pregnancy. Zagreb: Klinickatransfuziologija, 2000.
- Muhlbacher A, Michl U. Prevalence rate of red blood cell antibodies during gravidity in the Federal province Salzburg. Infusionsther Transfusionsmed 1999;26:348-52.
- Filbey D, Hanson U, Wesstrom G. The prevalence of red cell antibodies correlated to the outcome of the newborn. A 12 year study in central Sweden. Acta Obstet Gynecol Scand 1995;74:687-92.
- Brecker M, ed. Technical manual. 14th ed. Bethesda, MD: American Association of Blood Banks, 2003.
- Judd WJ, Luban NLC, Ness PM, et al. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion 1990;30:175-83.
- Contreras M, Garners SF. Laboratory procedures for the prediction of the severity of haemolytic disease of the newborn. Vox Sang 1995;59-63.
- Garratty G. Laboratory procedures for the prediction of the severity of haemolytic disease of the newborn, Vox Sang 1995;64-9.
- Daniels G. Human blood groups. Oxford: Blackwell Science,1995.
- Zupanska B. Clinical significance of alloantibodies. In: red cell immunohaematology. Proceedings of the European School of Transfusion Medicine 1998; 59-66.
- Bowell PJ, Inskip MJ, Jones MN. The significance of anti-C alloimmunization in pregnancy. Clin Lab Haematol 1988;10:251-5.
- Cheepsattayacorn R, Fongsatitkul L, Chotinaruemol S, et al. Anti-E as a cause of hemolytic disease of the newborn. J Med Assoc Thai 1997;Sep.80(Suppl 1).
- Bowell PJ, Brown SE, Dike AE, et al. The significance of anti-c alloimmunization in pregnancy. Br J Obstet Gynaecol 1986;93:1044-8.
- Lin SV, Lin DT, Hisieh SW, et al. Hemolytic disease of the newborn caused by anti-M antibody. J Formos Med Assoc 1996;95:390-2.
- De Yong-Owens, Kennedy M, Rose RL, et al. Anti-M isoimmunization management and outcome at the Ohio State University from 1969 to 1995. Obstet Gynecol 1997;90:962-6.
- Hadley AG. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn. Vox Sang 1998;74(Suppl 2):375-83.
- Moise KJ Jr. Non-anti-D antibodies in red cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000;Sep;92(1):75-81.
- Judd WJ. Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion 2001;41:1445-52.
DOI: https://doi.org/10.21307/immunohematology-2019-484 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 89 - 92
Published on: Oct 14, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2020 S. Jovanovic-Srzentic, M. Djokic, N. Tijanic, R. Djordjevic, N. Rizvan, D. Plecas, D. Filimonovic, published by American National Red Cross
This work is licensed under the Creative Commons License.